RxDoctor Payments Data

Todd Adams, DPM

Podiatrist · Cincinnati, OHNPI 1528061819

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Stryker at 38.1% of the total.

$7,983in general payments, 2019–2025

Across 140 payments — averaging $57.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Smith+Nephew$2K
  • Kerecis Limited$885
  • Organogenesis Inc.$716
  • Paragon 28, Inc.$255
  • Tulavi Therapeutics, Inc.$180
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$7,983100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,983 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$154,561
Medicare patients
486
Services billed
2,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox12$538
Methylprednisolone42$227
Ciprofloxacin Hcl17$169
Doxycycline Hyclate22$146
Meloxicam62$114
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$81

Paid to pharmacies, not to this prescriber.

Other podiatrist in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →